Day: February 15, 2021

Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients

Press release Synairgen plc(‘Synairgen’ or the ‘Company’)                                           Synairgen announces that dosing has commenced with its inhaled interferon beta product in...

Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatients

Press release Synairgen plc(‘Synairgen’ or the ‘Company’)                                           Synairgen announces that dosing has commenced with its inhaled interferon beta product in...

error: Content is protected !!